-
Signature
-
/s/ Stephen Vander Stoep, attorney-in-fact for Pamela J. Cramer
-
Issuer symbol
-
RYTM
-
Transactions as of
-
11 Dec 2025
-
Net transactions value
-
-$280,228
-
Form type
-
4
-
Filing time
-
15 Dec 2025, 16:30:16 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Cramer Pamela J. |
Chief Human Resources Officer |
C/O RHYTHM PHARMACEUTICALS, INC., 222 BERKELEY STREET, 12TH FLOOR, BOSTON |
/s/ Stephen Vander Stoep, attorney-in-fact for Pamela J. Cramer |
15 Dec 2025 |
0001873517 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RYTM |
Common Stock |
Options Exercise |
$91,622 |
+3,350 |
+16% |
$27.35 |
24,164 |
11 Dec 2025 |
Direct |
|
| transaction |
RYTM |
Common Stock |
Sale |
$371,850 |
-3,350 |
-14% |
$111.00 |
20,814 |
11 Dec 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RYTM |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-3,350 |
-29% |
$0.000000 |
8,375 |
11 Dec 2025 |
Common Stock |
3,350 |
$27.35 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: